Scientists at Institut Pasteur have gained new insights into how some people control HIV-1 replication after interruption of antiretroviral treatment (ART). The investigators found a fingerprint ...

The Federal Ministry of Health and Social Welfare, through the National AIDS, Viral Hepatitis and STIs Control Programme ...

The likelihood of HCV clearance was increased by participation in Ryan White services among patients with HIV coinfection.

Gilead is committed to using its virology expertise to advance HIV treatment and prevention to help end the epidemic. Since 2010, the company has partnered with Emory University in Atlanta to launch A ...

Last week, biotech bigwig Gilead Sciences, Inc. GILD reported lower-than-expected first-quarter 2025 results. Adjusted earnings per share (EPS) of $1.81 missed the Zacks Consensus Estimate by a penny.

The Illinois Department of Public Health has issued a standing order that will allow residents to obtain the HIV preventive ...

Among programs slated for elimination are ones disproportionately impacting LBGTQ people, including HIV prevention and ...

A panelist discusses how the HIV patient population has aged significantly, with the average age in their clinic now ...

GSK posted higher profit as sales for its specialty treatments including HIV, cancer and asthma beat expectations, offsetting lower vaccine sales on weak demand in the U.S.

GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand ...

In a first-ever milestone, Africa’s initial HIV cure trial has yielded historic findings: 20% of patients have remained off ...

An HIV patient in Laredo is sharing his advice with others living with the disease to raise awareness and highlight available ...